FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 198 filers reported holding FIBROGEN INC in Q2 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $245,000 | -6.5% | 7,056 | 0.0% | 0.02% | -9.1% |
| Q4 2020 | $262,000 | -9.7% | 7,056 | 0.0% | 0.02% | -12.0% |
| Q3 2020 | $290,000 | +1.4% | 7,056 | 0.0% | 0.02% | -30.6% |
| Q2 2020 | $286,000 | +16.7% | 7,056 | 0.0% | 0.04% | 0.0% |
| Q1 2020 | $245,000 | -19.1% | 7,056 | 0.0% | 0.04% | +9.1% |
| Q4 2019 | $303,000 | +16.1% | 7,056 | 0.0% | 0.03% | -17.5% |
| Q3 2019 | $261,000 | -18.2% | 7,056 | 0.0% | 0.04% | -21.6% |
| Q2 2019 | $319,000 | -16.7% | 7,056 | 0.0% | 0.05% | +2.0% |
| Q1 2019 | $383,000 | +17.1% | 7,056 | 0.0% | 0.05% | +16.3% |
| Q4 2018 | $327,000 | -17.8% | 7,056 | +7.6% | 0.04% | -25.9% |
| Q3 2018 | $398,000 | -2.9% | 6,556 | 0.0% | 0.06% | -15.9% |
| Q2 2018 | $410,000 | +35.3% | 6,556 | 0.0% | 0.07% | +27.8% |
| Q1 2018 | $303,000 | -2.6% | 6,556 | 0.0% | 0.05% | -6.9% |
| Q4 2017 | $311,000 | +4.0% | 6,556 | +18.0% | 0.06% | -9.4% |
| Q3 2017 | $299,000 | – | 5,556 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |